Both HPGD and SLCO2A1 deficiency can independently lead to failure of PGE2 degradation, resulting in elevated levels of prostaglandin E2 (PGE2) in the circulation, which is thought to contribute to the pathogenesis for PHO (1, 6). Here, SLCO2A1 is linked to primary hypertrophic osteoarthropathy.